Pro-ocular (progesterone gel) / SIFI, Glia  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pro-ocular (progesterone gel) / Glia, SIFI
NCT02656394: Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101

Completed
2
49
US
GL101, Pro-Ocular, Placebo
Glia, LLC
Ocular Surface Disease
12/17
12/18
NCT04884217: Treatment of Dry Eye Disease Using Pro-ocularâ„¢ - A Proof of Concept, Safety, and Efficacy Study

Enrolling by invitation
2
80
RoW
Pro-ocularâ„¢ Topical Gel, PG101, Placebo Topical Gel
PharmaDax Inc., Glia, LLC
Dry Eye Syndrome, Keratoconjunctivitis Sicca
10/21
12/21
NCT03990051: Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.

Completed
2
33
US
Pro-ocular™ topical gel, Placebo topical gel
Glia, LLC, ORA, Inc.
Chronic Ocular Graft-versus-host Disease
10/21
11/21
ProGIFT, NCT04645446 / 2019-000747-27: Safety and Efficacy of Two Different Concentrations (0.5% and 1%) of Progesterone Topical Gel Compared to Placebo in Patients Diagnosed With Moderate to Severe Dry Eye Syndrome

Completed
2
96
Europe
Pro-ocular gel, Placebo gel
SIFI SpA
Dry Eye Disease
10/22
10/22

Download Options